FiercePharma

Jazz's Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow

Those who have the sleep disorder idiopathic hypersomnia finally have relief. But it comes in the form of a medicine with tight regulations and safety concerns. On Thursday, Jazz Pharmaceuticals ...
Managed Healthcare Executive

Music shows promise for sleep while many wellness apps lack strong proof

Music, white noise and bedtime stories are often promoted as easier ways to help people sleep better. Many of these tools are found in popular sleep apps and are marketed as low-risk wellness products ...
Reuters

U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav

Aug 12 (Reuters) - Jazz Pharmaceuticals PLC (JAZZ.O), opens new tab said on Thursday its sleep disorder drug Xywav received U.S. regulatory approval for the expanded use in patients suffering from ...
FiercePharma

Too, too tired? Jazz launches awareness push aimed at sleep apnea sufferers

Droopy eyelids might happen to anyone after a sleepless night, but for some people they're all too chronic—and Jazz Pharma wants to treat those people. That's why it's running a new awareness campaign ...
MM&M

Jazz Pharmaceuticals, AHA sync up to hit the right note on sleep disorder awareness

For years, Jazz Pharmaceuticals and the American Heart Association (AHA) have partnered on health education, focusing specifically on raising awareness about sleep disorders. Now, Jazz said it’s ...